Mutual collaboration is key to Korea's successful new drug development

Published: 2006-11-20 06:57:00

Updated: 2006-11-20 06:57:00

There is mounting consensus in domestic pharmaceutical industry that the breakthrough for better competitiveness of Korean pharmaceutical firms in the global arena is to ensure the efficiency of R&D spending through a closer collaboration between industry, academia and research labs.

Links wit...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK